Source link : https://newshealth.biz/health-news/investigational-oral-drug-shows-promise-in-genetic-bleeding-disorder/
(MedPage Today) — Treatment with the investigational oral, allosteric, selective AKT inhibitor engasertib appeared to be safe in patients with hereditary hemorrhagic telangiectasia (HHT), and was associated with decreases in epistaxis frequency… Source link : https://www.medpagetoday.com/hematologyoncology/hematology/118745 Author : Publish date : 2025-11-26 22:00:00 Copyright for syndicated content belongs to the linked Source.
The post Investigational Oral Drug Shows Promise in Genetic Bleeding Disorder first appeared on News Health.
—-
Author : News Health
Publish date : 2025-11-26 22:00:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8